XML 92 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Selected Quarterly Financial Information - Summary of Company's Selected Quarterly Financial Information (Detail) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]      
Net revenue $ 1,972,021 $ 1,911,191 $ 1,733,951
Practice salaries and benefits 1,383,319 1,297,477 1,193,940
Practice supplies and other operating expenses 121,669 100,472 90,690
General and administrative expenses 231,397 263,357 248,947
Gain on sale of building 0 (7,280) 0
Depreciation and amortization 35,636 32,147 28,441
Transformational and restructuring related expenses 27,312 22,100 73,801
Total operating expenses 1,799,333 1,708,273 1,635,819
Income from operations 172,688 202,918 98,132
Investment and other (expense) income 3,671 13,652 17,913
Interest expense (39,695) (68,722) (110,482)
Loss on early extinguishment of debt (57,016) (14,532) 0
Equity in earnings of unconsolidated affiliates 1,722 1,912 1,585
Total non-operating expenses (91,318) (67,690) (90,984)
(Loss) income from continuing operations before income taxes 81,370 135,228 7,148
Income tax benefit (provision) (18,806) (27,241) (16,728)
Income (loss) from continuing operations 62,564 107,987 (9,580)
(Loss) income from discontinued operations, net of tax 3,767 22,950 (786,908)
Net income (loss) 66,331 130,937 (796,488)
Net income (loss) attributable to Pediatrix Medical Group, Inc. $ 66,335 $ 130,964 $ (796,488)
Income from continuing operations, Basic $ 0.75 $ 1.27 $ (0.11)
Income from continuing operations, Diluted 0.74 1.26 (0.11)
Loss from discontinued operations, Basic 0.04 0.27 (9.44)
Loss from discontinued operations, Diluted 0.05 0.27 (9.44)
Earnings Per Share, Basic 0.79 1.54 (9.55)
Earnings Per Share, Diluted $ 0.79 $ 1.53 $ (9.55)
Weighted Average Number of Shares Outstanding, Basic 83,467 84,832 83,395
Weighted average shares, Diluted 84,121 85,828 83,395